Naomi R M Schwartz (Naomi Rm Schwartz)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Emergency Department

Epidermal Growth Factor Receptor

Irritable Bowel Syndrome

Positive Breast Cancer

Top Venues

The Journal of nutrition

Future oncology (London, England)

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Naomi R M Schwartz, Myriam C Afeiche, Kathryn L Terry, Leslie V Farland, Jorge E Chavarro, Stacey A Missmer, Holly R Harris
Glycemic Index, Glycemic Load, Fiber, and Gluten Intake and Risk of Laparoscopically Confirmed Endometriosis in Premenopausal Women. The Journal of nutrition 152 (9) (2022)
Robert J Romanelli, Naomi R M Schwartz, William G Dixon, Carla Rodriguez-Watson, Brian C Sauer, Dawn Albright, Zachary A Marcum
The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology. Pharmacoepidemiology and drug safety 30 (10) (2021)
Naomi R M Schwartz, Ronit R Dalmat
Letter to the editor concerning Kuksis et al. Neuro-oncology 23 (8) (2021)
Naomi R M Schwartz, Kendra DeBusk, Andres Forero-Torres, Joseph Feliciano, Vamshi Ruthwik Anupindi, Jason Yeaw, Ali McBride
Economic burden of central nervous system metastases in human epidermal growth factor receptor 2-positive breast cancer. Future oncology (London, England) 17 (26) (2021)